SIM
ACUR

Spark Investment Management’s Acura Pharmaceuticals ACUR Stock Holding History

Spark Investment Management’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-15,755
Closed -$39K – 913
2015
Q4 		$39K Sell
15,755
-2,824
-15% -$6.87K 0.01% 727
2015
Q3 		$43K Buy
18,579
+11,539
+164% +$39.3K 0.01% 651
2015
Q2 		$34K Buy
+7,040
New +$29.2K ﹤0.01% 640
2015
Q1 		– Sell
-2,240
Closed -$5K – 815
2014
Q4 		$5K Hold
2,240
– – ﹤0.01% 680
2014
Q3 		$8K Buy
+2,240
New +$10.5K ﹤0.01% 661
2014
Q2 		– Sell
-5,860
Closed -$42K – 819
2014
Q1 		$42K Buy
5,860
+3,400
+138% +$29.5K 0.01% 645
2013
Q4 		$20K Buy
+2,460
New +$20.8K ﹤0.01% 637

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Spark Investment Management's ACUR Position: Q1 2016 in Review

Spark Investment Management sold out of Acura Pharmaceuticals (ACUR) in Q1 2016, closing a stake of 15,755 shares — an estimated $39K sold.

Spark Investment Management first reported a position in ACUR in Q4 2013 and held it in 7 quarters. The position peaked at $43K in Q3 2015. 22 funds tracked by Wall St. Rank hold ACUR as of Q1 2016.

  • Spark Investment Management reported no remaining Acura Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 15,755 Acura Pharmaceuticals shares in Q1 2016, an estimated $39K.
  • Spark Investment Management first reported a position in Acura Pharmaceuticals in Q4 2013 and held it in 7 quarters.
  • Spark Investment Management's Acura Pharmaceuticals position peaked at $43K in Q3 2015.
  • 22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.